Self-administered injectable contraceptives, which are progestin-only shots taken at home every three months, have been ...
Self-administered injectable contraceptives have been available in the United States for more than two decades, yet a new ...
At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...
Recent studies how found evidence that Depo-Provera massively increases the risk of developing brain tumors even after women ...
The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...
The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...
U.S. government regulators have approved a new brain tumor warning for Depo-Provera Lawsuits from more than 1,000 women claim they weren’t warned sooner Regulators in Europe and Canada previously ...
FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...
The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...
If you took the warning label that comes with your birth control and tossed it right in the trash, you wouldn’t be alone. After all, every medication comes with a risk of side effects, and those ...
The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...
The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results